The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs

Abstract Recombinant vesicular stomatitis viruses (rVSVs) engineered to express heterologous viral glycoproteins have proven to be remarkably effective vaccines. Indeed, rVSV-EBOV, which expresses the Ebola virus (EBOV) glycoprotein, recently received clinical approval in the United States and Europ...

詳細記述

書誌詳細

主要な著者:	Wenguang Cao, Shihua He, Guodong Liu, Helene Schulz, Karla Emeterio, Michael Chan, Kevin Tierney, Kim Azaransky, Geoff Soule, Nikesh Tailor, Abdjeleel Salawudeen, Rick Nichols, Joan Fusco, David Safronetz, Logan Banadyga
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Portfolio 2023-06-01
シリーズ:	npj Vaccines
オンライン･アクセス:	https://doi.org/10.1038/s41541-023-00685-z
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!